Literature DB >> 23815542

Vascular endothelial growth factor: a novel potential therapeutic target for hypertension.

Hui Tao, Kai-Hu Shi, Jing-Jing Yang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23815542      PMCID: PMC8033882          DOI: 10.1111/jch.12129

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  4 in total

1.  AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.

Authors:  Christopher T Banek; Ashley J Bauer; Karen M Needham; Hans C Dreyer; Jeffrey S Gilbert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-15       Impact factor: 4.733

2.  Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans.

Authors:  Anna M J Thijs; Carla M L van Herpen; Fred C G J Sweep; Anneke Geurts-Moespot; Paul Smits; Winette T A van der Graaf; Gerard A Rongen
Journal:  Hypertension       Date:  2013-03-18       Impact factor: 10.190

3.  Vascular endothelial growth factor-A and aldosterone: relevance to normal pregnancy and preeclampsia.

Authors:  Carine Gennari-Moser; Eliyahu V Khankin; Geneviève Escher; Fiona Burkhard; Brigitte M Frey; S Ananth Karumanchi; Felix J Frey; Markus G Mohaupt
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

4.  Malignant hypertension in patients treated with vascular endothelial growth factor inhibitors.

Authors:  Jara Caro; Enrique Morales; Eduardo Gutierrez; Luis Miguel Ruilope; Manuel Praga
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-12-19       Impact factor: 3.738

  4 in total
  1 in total

1.  Reply to vascular endothelial growth factor: a novel potential therapeutic target for hypertension.

Authors:  Enrique Morales; Morales Enrique; Jara Caro; Caro Jara
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-05-17       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.